16 drug(s) with this reaction
5,448 total reports
Somnolence has been reported as an adverse reaction across 16 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 5,448 adverse event reports mention somnolence in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with somnolence, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have somnolence listed in their FDA adverse event reports, sorted by report count:
In addition to somnolence, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
16 drug(s) manufactured by Haleon Us Holdings Llc have somnolence listed in their FDA adverse event reports: FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, IBUPROFEN SODIUM, IBUPROFEN TABLETS, COATED, NICOTINE, and others.
There are a combined 5,448 reports of somnolence across 16 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.